PubRank

Tatsuo Miyamura

Author PubWeight™ 128.67‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 2002 5.71
2 Molecular epidemiology of enterovirus 71 infection in the Western Pacific Region. Pediatr Int 2004 3.06
3 Persistence of oral polio vaccine virus after its removal from the immunisation schedule in New Zealand. Lancet 2005 3.01
4 Interaction of hepatitis C virus nonstructural protein 5A with core protein is critical for the production of infectious virus particles. J Virol 2008 2.74
5 Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med 2009 2.73
6 Hepatitis E virus transmission from wild boar meat. Emerg Infect Dis 2005 2.55
7 Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993. J Virol 2003 2.51
8 Genetic and antigenic diversity among noroviruses. J Gen Virol 2006 1.91
9 Hepatitis C virus RNA replication is regulated by FKBP8 and Hsp90. EMBO J 2006 1.89
10 Human VAP-B is involved in hepatitis C virus replication through interaction with NS5A and NS5B. J Virol 2005 1.86
11 Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structure. Proc Natl Acad Sci U S A 2009 1.82
12 Pyramidal and extrapyramidal involvement in experimental infection of cynomolgus monkeys with enterovirus 71. J Med Virol 2002 1.78
13 Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. MBio 2014 1.76
14 Proteasome activator PA28gamma-dependent nuclear retention and degradation of hepatitis C virus core protein. J Virol 2003 1.76
15 Proteomic profiling of lipid droplet proteins in hepatoma cell lines expressing hepatitis C virus core protein. J Biochem 2006 1.71
16 Critical role of virion-associated cholesterol and sphingolipid in hepatitis C virus infection. J Virol 2008 1.65
17 Noroviruses distinguish between type 1 and type 2 histo-blood group antigens for binding. J Virol 2008 1.65
18 Temperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeys. J Gen Virol 2005 1.60
19 Pathogenesis of lipid metabolism disorder in hepatitis C: polyunsaturated fatty acids counteract lipid alterations induced by the core protein. J Hepatol 2010 1.58
20 Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001. J Virol 2004 1.55
21 Critical role of PA28gamma in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis. Proc Natl Acad Sci U S A 2007 1.45
22 Essential elements of the capsid protein for self-assembly into empty virus-like particles of hepatitis E virus. J Virol 2005 1.43
23 Differential localization of neurons susceptible to enterovirus 71 and poliovirus type 1 in the central nervous system of cynomolgus monkeys after intravenous inoculation. J Gen Virol 2004 1.43
24 Intramembrane proteolysis and endoplasmic reticulum retention of hepatitis C virus core protein. J Virol 2004 1.40
25 Structure of hepatitis E virion-sized particle reveals an RNA-dependent viral assembly pathway. J Biol Chem 2010 1.40
26 Molecular typing and epidemiology of non-polio enteroviruses isolated from Yunnan Province, the People's Republic of China. J Med Virol 2008 1.34
27 A norovirus protease structure provides insights into active and substrate binding site integrity. J Virol 2005 1.34
28 Molecular determinants for subcellular localization of hepatitis C virus core protein. J Virol 2005 1.31
29 Interaction of hepatitis C virus core protein with retinoid X receptor alpha modulates its transcriptional activity. Hepatology 2002 1.30
30 A Sabin 3-derived poliovirus recombinant contained a sequence homologous with indigenous human enterovirus species C in the viral polymerase coding region. J Virol 2005 1.23
31 Intratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient. J Virol 2005 1.22
32 Protection of cynomolgus monkeys against HEV infection by oral administration of recombinant hepatitis E virus-like particles. Vaccine 2004 1.20
33 E6AP ubiquitin ligase mediates ubiquitylation and degradation of hepatitis C virus core protein. J Virol 2006 1.19
34 Genogroup II noroviruses efficiently bind to heparan sulfate proteoglycan associated with the cellular membrane. J Virol 2004 1.16
35 Structural analysis of vaccinia virus DIs strain: application as a new replication-deficient viral vector. Virology 2002 1.16
36 Identification of active-site amino acid residues in the Chiba virus 3C-like protease. J Virol 2002 1.14
37 Proteolytic processing of sapovirus ORF1 polyprotein. J Virol 2005 1.13
38 Latent infection of a new alphanodavirus in an insect cell line. J Virol 2007 1.11
39 Oligomerization of hepatitis C virus core protein is crucial for interaction with the cytoplasmic domain of E1 envelope protein. J Virol 2006 1.11
40 Prevalence of vaccine-derived polioviruses in the environment. J Gen Virol 2002 1.10
41 Production of infectious hepatitis C virus by using RNA polymerase I-mediated transcription. J Virol 2010 1.10
42 Involvement of the PA28gamma-dependent pathway in insulin resistance induced by hepatitis C virus core protein. J Virol 2006 1.08
43 Hepatitis C virus core protein activates ERK and p38 MAPK in cooperation with ethanol in transgenic mice. Hepatology 2003 1.06
44 Spatial configuration of hepatitis E virus antigenic domain. J Virol 2010 1.05
45 Complete genomic sequence and comparative analysis of the tumorigenic poxvirus Yaba monkey tumor virus. J Virol 2003 1.05
46 Proteomics analysis of mitochondrial proteins reveals overexpression of a mitochondrial protein chaperon, prohibitin, in cells expressing hepatitis C virus core protein. Hepatology 2009 1.03
47 Spontaneous elimination of serum hepatitis C virus (HCV) RNA in chronic HCV carriers: a population-based cohort study. J Med Virol 2003 1.01
48 Structure and assembly of a T=1 virus-like particle in BK polyomavirus. J Virol 2005 1.00
49 Hepatitis C virus core protein exerts an inhibitory effect on suppressor of cytokine signaling (SOCS)-1 gene expression. J Hepatol 2005 0.99
50 Characterization of the norovirus 3C-like protease. Virus Res 2005 0.99
51 Quantitative analysis of poliomyelitis-like paralysis in mice induced by a poliovirus replicon. J Gen Virol 2006 0.98
52 Shifting seroepidemiology of hepatitis A in Japan, 1973-2003. Microbiol Immunol 2007 0.98
53 Prevalence of hepatitis C virus subgenotypes 1a and 1b in Japanese patients: ultra-deep sequencing analysis of HCV NS5B genotype-specific region. PLoS One 2013 0.97
54 Detection of hepatitis E virus RNA from the bivalve Yamato-Shijimi (Corbicula japonica) in Japan. Am J Trop Med Hyg 2007 0.97
55 Identification of annexin A1 as a novel substrate for E6AP-mediated ubiquitylation. J Cell Biochem 2009 0.97
56 Antigenic characterization of a formalin-inactivated poliovirus vaccine derived from live-attenuated Sabin strains. Vaccine 2007 0.96
57 Proteasomal turnover of hepatitis C virus core protein is regulated by two distinct mechanisms: a ubiquitin-dependent mechanism and a ubiquitin-independent but PA28gamma-dependent mechanism. J Virol 2008 0.96
58 Characterization of self-assembled virus-like particles of human polyomavirus BK generated by recombinant baculoviruses. Virology 2003 0.96
59 Involvement of creatine kinase B in hepatitis C virus genome replication through interaction with the viral NS4A protein. J Virol 2009 0.96
60 Antiapoptotic regulation by hepatitis C virus core protein through up-regulation of inhibitor of caspase-activated DNase. Virology 2003 0.95
61 Mice are not susceptible to hepatitis E virus infection. J Vet Med Sci 2008 0.94
62 Identification of the cleavage sites of sapovirus open reading frame 1 polyprotein. J Gen Virol 2006 0.93
63 Differential cellular gene expression induced by hepatitis B and C viruses. Biochem Biophys Res Commun 2003 0.93
64 A single-amino-acid mutation in hepatitis C virus NS5A disrupting FKBP8 interaction impairs viral replication. J Virol 2008 0.93
65 Chaperonin TRiC/CCT participates in replication of hepatitis C virus genome via interaction with the viral NS5B protein. Virology 2010 0.93
66 Down-regulation of the internal ribosome entry site (IRES)-mediated translation of the hepatitis C virus: critical role of binding of the stem-loop IIId domain of IRES and the viral core protein. Virology 2005 0.92
67 Diverging effects of human recombinant anti-hepatitis C virus (HCV) antibody fragments derived from a single patient on the infectivity of a vesicular stomatitis virus/HCV pseudotype. J Virol 2002 0.92
68 Alteration of intrahepatic cytokine expression and AP-1 activation in transgenic mice expressing hepatitis C virus core protein. Virology 2002 0.92
69 Virological characterization of the hepatitis C virus JFH-1 strain in lymphocytic cell lines. J Gen Virol 2008 0.92
70 Characterization of HCV-like particles produced in a human hepatoma cell line by a recombinant baculovirus. Biochem Biophys Res Commun 2005 0.91
71 Structural requirements of virion-associated cholesterol for infectivity, buoyant density and apolipoprotein association of hepatitis C virus. J Gen Virol 2011 0.90
72 Trans-encapsidation of hepatitis C virus subgenomic replicon RNA with viral structure proteins. Biochem Biophys Res Commun 2008 0.90
73 Serologic evidence for hepatitis E virus infection in mongoose. Am J Trop Med Hyg 2006 0.90
74 Production and release of infectious hepatitis C virus from human liver cell cultures in the three-dimensional radial-flow bioreactor. Virology 2003 0.89
75 Quantitative detection of hepatitis C virus (HCV) RNA in saliva and gingival crevicular fluid of HCV-infected patients. J Clin Microbiol 2005 0.88
76 Expression profiling of liver cell lines expressing entire or parts of hepatitis C virus open reading frame. Hepatology 2002 0.88
77 Alanine aminotransferase elevation during peginterferon alpha-2a or alpha-2b plus ribavirin treatment. Int J Med Sci 2013 0.88
78 A retrospective study on imported hepatitis E in Japan. Travel Med Infect Dis 2012 0.87
79 Enhancement of de novo fatty acid biosynthesis in hepatic cell line Huh7 expressing hepatitis C virus core protein. Biol Pharm Bull 2006 0.87
80 Long-Term Persistent GBV-B Infection and Development of a Chronic and Progressive Hepatitis C-Like Disease in Marmosets. Front Microbiol 2011 0.86
81 Cellular vimentin content regulates the protein level of hepatitis C virus core protein and the hepatitis C virus production in cultured cells. Virology 2008 0.86
82 Challenges in creating a vaccine to prevent hepatitis E. Vaccine 2005 0.85
83 Crystallization and preliminary X-ray diffraction analysis of recombinant hepatitis E virus-like particle. Acta Crystallogr Sect F Struct Biol Cryst Commun 2008 0.85
84 Antiviral activity of glycyrrhizin against hepatitis C virus in vitro. PLoS One 2013 0.84
85 GBV-B as a pleiotropic virus: distribution of GBV-B in extrahepatic tissues in vivo. Microbes Infect 2007 0.84
86 Efficient production of type 2 porcine circovirus-like particles by a recombinant baculovirus. Arch Virol 2008 0.84
87 All-trans retinoic acid down-regulates human albumin gene expression through the induction of C/EBPbeta-LIP. Biochem J 2006 0.84
88 Immunological detection of severe acute respiratory syndrome coronavirus by monoclonal antibodies. Jpn J Infect Dis 2005 0.83
89 Production of infectious hepatitis C virus particles in three-dimensional cultures of the cell line carrying the genome-length dicistronic viral RNA of genotype 1b. Virology 2006 0.83
90 Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells transduced with replication-defective recombinant adenovirus. Vaccine 2002 0.83
91 Application of an automated specimen search system installed in a transmission electron microscope for the detection of caliciviruses in clinical specimens. J Virol Methods 2002 0.81
92 Different effects of three interferons L on Toll-like receptor-related gene expression in HepG2 cells. Cytokine 2013 0.81
93 Identification of hepatitis C virus genotype 2a replicon variants with reduced susceptibility to ribavirin. Antiviral Res 2010 0.81
94 Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIs. Virology 2006 0.81
95 E6AP ubiquitin ligase mediates ubiquitin-dependent degradation of peroxiredoxin 1. J Cell Biochem 2010 0.81
96 Infection of HepG2 cells with recombinant adenovirus encoding the HCV core protein induces p21(WAF1) down-regulation -- effect of transforming growth factor beta. J Hepatol 2002 0.80
97 Immunization with recombinant Calmette-Guerin bacillus (BCG)-hepatitis C virus (HCV) elicits HCV-specific cytotoxic T lymphocytes in mice. Vaccine 2003 0.80
98 [Cumulative vaccination coverage of measles- and oral polio vaccine obtained by the nationwide survey]. Kansenshogaku Zasshi 2005 0.79
99 Rapid serological diagnosis of enterovirus 71 infection by IgM ELISA. Jpn J Infect Dis 2002 0.79
100 Interleukin-29 suppresses hepatitis A and C viral internal ribosomal entry site-mediated translation. Viral Immunol 2012 0.79
101 Platelet count and sustained virological response in hepatitis C treatment. World J Hepatol 2013 0.79
102 Characterization of in vitro and in vivo phenotypes of poliovirus type 1 mutants with reduced viral protein synthesis activity. J Gen Virol 2004 0.78
103 Identification of basal promoter and enhancer elements in an untranslated region of the TT virus genome. J Virol 2004 0.78
104 Peginterferon Alfa-2a plus ribavirin in Japanese patients infected with hepatitis C virus genotype 2 who failed previous interferon therapy. Int J Med Sci 2012 0.77
105 Identification and characterization of the human inhibitor of caspase-activated DNase gene promoter. Apoptosis 2008 0.76
106 Tacrolimus ameliorates metabolic disturbance and oxidative stress caused by hepatitis C virus core protein: analysis using mouse model and cultured cells. Am J Pathol 2009 0.76
107 [Leprosy in a chimpanzee]. Nihon Hansenbyo Gakkai Zasshi 2011 0.75
108 Acute liver failure in an antimitochondrial antibody-positive 63-year-old man. Case Rep Gastroenterol 2012 0.75
109 [Hepatitis E]. Nihon Rinsho 2003 0.75
110 Highly attenuated vaccinia virus DIs as a potential SARS vaccine. Adv Exp Med Biol 2006 0.75
111 [Structure of HEV]. Nihon Rinsho 2004 0.75
112 Chimpanzees used for medical research shed light on the pathoetiology of leprosy. Future Microbiol 2011 0.75
113 [Detection of antibodies of HEV]. Nihon Rinsho 2004 0.75
114 [Pulmonary nocardiosis associated with the treatment of severe liver injury]. Nihon Shokakibyo Gakkai Zasshi 2014 0.75
115 [Hepatitis E vaccine]. Nihon Rinsho 2004 0.75
116 Surveillance of poliovirus-isolates in Japan, 2002. Jpn J Infect Dis 2003 0.75
117 [History of the discovery of viral hepatitis]. Nihon Rinsho 2015 0.75
118 [Hepatitis C virus replication associated with lipid rafts]. Seikagaku 2006 0.75
119 Outbreak of hepatitis C virus infection in an outpatient clinic. J Gastroenterol Hepatol 2005 0.75
120 Dynamic behavior of hepatitis C virus quasispecies in a long-term culture of the three-dimensional radial-flow bioreactor system. J Virol Methods 2008 0.75
121 Surveillance of poliovirus-isolates in Japan, 2001. Jpn J Infect Dis 2002 0.75